← Leaderboards
Anthony T Podany
University Of Nebraska Medical Center
$1,394,818
Attributed
$2,546,544
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $927.2K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,546,544 · 3
By mechanism
R56$927,200 · 1
K23$818,955 · 1
R01$800,389 · 1
Top collaborators
- Vijayakumar Velu2 shared
- Francois J Villinger2 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Guoku Hu$2,353,332
- Minglei Guo$7,203,802
- Palsamy Periyasamy$2,825,222
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionSafetyNovel TherapeuticsIn VivoAntiretroviral TherapyMorbidity - Disease RateIn VitroMortalityDrug InteractionsBaseChronic DiseaseAntibioticsAids Clinical Trial GroupDoseDrug KineticsAwardCommunicable DiseasesCyp2b6 GeneCytochrome P450ComparativeCenters For Disease Control And Prevention (U.S.)Cessation Of LifeCharacteristicsClinical Research
Grant awards (7)
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$800,389
R01 · FY2025 · AI
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$927,200
R56 · FY2024 · AI
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine$162,603
K23 · FY2022 · AI · contact PI
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine$162,768
K23 · FY2021 · AI · contact PI
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine$163,848
K23 · FY2020 · AI · contact PI
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine$164,763
K23 · FY2019 · AI · contact PI
Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine$164,973
K23 · FY2018 · AI · contact PI